Gilead to Expand Coronavirus Drug Trials to Other Countries

The drug maker Gilead Sciences is expanding its clinical trials of the antiviral drug remdesivir as a possible coronavirus treatment into several countries outside China, the company announced on Wednesday.

Two new clinical trials of remdesivir are to begin in March, involving “approximately 1,000 patients at medical centers primarily across Asian countries, as well as other countries globally with high numbers of diagnosed cases,” Gilead said in a statement. It did not specify the countries where the trials will take place.